Literature DB >> 4170638

Pyoderma gangrenosum treated with 6-mercaptopurine and followed by acute leukemia.

N Maldonado, V M Torres, D Méndez-Cashion, E Pérez-Santiago, M Cáceres de Costas.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1968        PMID： 4170638     DOI： 10.1016/s0022-3476(68)80218-5

Source DB:  PubMed          Journal:  J Pediatr        ISSN： 0022-3476            Impact factor:   4.406


× No keyword cloud information.
  7 in total

1.  Familial pyoderma gangrenosum presenting in infancy.

Authors:  H S al-Rimawi; F M Abuekteish; A S Daoud; M M Oboosi
Journal:  Eur J Pediatr       Date:  1996-09       Impact factor: 3.183

2.  Pyoderma gangrenosum in acute myeloid leukaemia during immunosuppression.

Authors:  P C van de Kerkhof; G A de Vaan; R Holland
Journal:  Eur J Pediatr       Date:  1988-10       Impact factor: 3.183

3.  Acute leukemia after cytotoxic treatment for nonmalignant disease in childhood. A case report and review of the literature.

Authors:  W Müller; M Brandis
Journal:  Eur J Pediatr       Date:  1981-03       Impact factor: 3.183

4.  Pyoderma gangrenosum in myelodysplasia and acute leukaemia.

Authors:  P Jacobs; S Palmer; E C Gordon-Smith
Journal:  Postgrad Med J       Date:  1985-08       Impact factor: 2.401

5.  Acute leukaemia during azathioprine therapy.

Authors:  I T Gilmore; G Holden; K S Rodan
Journal:  Postgrad Med J       Date:  1977-03       Impact factor: 2.401

6.  Diagnosis and management of parastomal pyoderma gangrenosum.

Authors:  Xian-Rui Wu; Bo Shen
Journal:  Gastroenterol Rep (Oxf)       Date:  2013-04-19

7.  Modulation of the Notch System in Response to Wnt Inhibition Induces Restoration of the Rat Luteal Function.

Authors:  Paula Accialini; Andrés Bechis; Griselda Irusta; Maria Silvia Bianchi; Fernanda Parborell; Dalhia Abramovich; Marta Tesone
Journal:  Reprod Sci       Date:  2020-01-06       Impact factor: 3.060
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.